Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-14

Clinical Trial Update: A Study of Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective Disorder [Phase 1]

View source ↗

Summary

Clinical trial update indicating completion of Phase 1 evaluation of aripiprazole lauroxil in adults with schizophrenia or schizoaffective disorder. The entry n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARISTADA (ARIPIPRAZOLE LAUROXIL)

Snippet

Sponsor: Alkermes, Inc. | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 1 | Status: COMPLETED